Inclusion and Diversity in Clinical Trials Awardees
The intent of the Inclusion and Diversity in Screening, Diagnosis, and Cancer Clinical Trials grant is to support projects that have the potential to increase participation and diversity in cancer clinical trials. Many barriers exist to clinical trials participation, including but not limited to initial screening and diagnosis, the capacity and infrastructure at clinical trial sites, and understanding and addressing the needs of potential clinical trial participants. As such, this grant may support projects that enhance clinical trial site capacity or infrastructure to conduct cancer clinical trials or address patients’ barriers to participation. The grant may not be used to purchase real property.
Cycle 1
May 2023
Guiding Participation toward Understanding, Inclusion, Diversity, and Equity for Cancer Clinical Trials (GUIDE)
Fred Hutchinson Cancer Center (Principal Investigator: Jason Mendoza, MD, MPH)Optimizing Clinical Trials Access to Ensure Inclusion and Diversity
Fred Hutchinson Cancer Center (Principal Investigator: Joseph Unger, PhD)Increasing Cervical Cancer Screening and Diagnosis among Sexual Minority Women-A Community Engaged Intervention
MultiCare Health System (Principal Investigator: Deana Williams, PhD)Promoting Patient Diversity, Inclusion, and Access to Cancer Clinical Trials through Navigation–A Community Oncology Diversity Project
MultiCare Health System (Principal Investigator: Deana Williams, PhD)Improving Diversity and Inclusion in Therapeutic Studies for Children with Cancer in Washington State
Seattle Children’s Research Institute (Principal Investigator: Sarah Leary, MD)Adapting Research Design & Systems to Improve Inclusion & Diversity in Cancer Clinical Trials
University of Washington (Principal Investigator: Shaveta Vinayak, MD)